Global Substance Abuse Treatment Market to Reach $18.8 Billion by 2030
The global market for Substance Abuse Treatment estimated at US$10.7 Billion in the year 2022, is projected to reach a revised size of US$18.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2022-2030. Nicotine Addiction Treatment, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$8.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Alcohol Addiction Treatment segment is readjusted to a revised 7.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 6.6% CAGR
The Substance Abuse Treatment market in the U.S. is estimated at US$3.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 6.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.Select Competitors (Total 47 Featured) -
- Alkermes PLC
- Allergan PLC
- GlaxoSmithKline PLC
- Mallinckrodt, Inc.
- Mylan NV
- Pfizer, Inc.
- Purdue Pharma LP
- Reckitt Benckiser Group plc
- Sanofi S.A.
- Teva Pharmaceuticals USA, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alkermes PLC
- Allergan PLC
- GlaxoSmithKline PLC
- Mallinckrodt, Inc.
- Mylan NV
- Pfizer, Inc.
- Purdue Pharma LP
- Reckitt Benckiser Group plc
- Sanofi S.A.
- Teva Pharmaceuticals USA, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 197 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 10.7 Billion |
Forecasted Market Value ( USD | $ 18.8 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |